Working at<br />CONTINUUS

Working at

CONTINUUS Pharmaceuticals is a spin-out company from a multi-year collaboration between MIT and Novartis. We specialize in end-to-end Integrated Continuous Manufacturing (ICM), with the application of novel process technologies that enable the rapid production of pharmaceuticals at significantly reduced costs and better quality assurance. With ICM, we will improve affordability and accessibility of pharmaceuticals on a global scale.


CONTINUUS is leveraging a novel continuous manufacturing platform called Integrated Continuous Manufacturing (ICM), which will transform and streamline the supply chain of pharmaceuticals, by delivering high quality lower cost drugs “on-demand.”  ICM was initially developed through an $85 M joint research project between Novartis and MIT.

With ICM, we will transform the pharmaceutical industry by converting fragmented batch processes to seamless ICM lines.

We are looking to expand our fantastic team with more talented Individuals. Join us on our exciting journey!

A New Paradigm

The Past:  Batch manufacturing is an outdated methodology that suffers from a series of “stop-and-start” steps in its production chain. This includes the isolation and transportation of chemical intermediates across different unit operations, often located in different facilities, where quality issues can occur. This entire process is very time- and cost-inefficient.

Batch processes are lengthy, and often fragmented and uncoordinated

The Future:  ICM represents the most advanced manufacturing platform for pharmaceuticals. Innovative unit operations enable the seamless integration of API and drug product manufacturing. Batch processes that require over a year can be shortened to just a few days. Fully automated production lines can be easily re-configured in a “plug-and-play” fashion to produce many different compounds.

ICM processes are seamless and time- and cost-effective



  • Shorter development times
  • Reduced scale-up from development to manufacturing
  • Fast to market


  • Reduced lead times
  • Decreased COGS
  • Higher flexibility during launch
  • Small footprint
  • Decreased inventory

Sales / Distribution

  • Regional manufacturing and distribution network
  • Increased responsiveness to changes in demand

Patient Care

  • Reduced possibility of drug shortage
  • Improved product quality

Improving Drug Development

ICM will enhance drug development efforts, accelerating the availability of life-saving drugs

Leaning the Supply Chain

More reliable and cost- and time-effective manufacturing will enable a more robust and efficient supply chain

Delivering Better Care

Patients will have better access to high-quality and more affordable drugs

Employee Testimonials

Bhakti Halkude, Sr. Manager:

CONTINUUS is my second family. My favorite part about working here is getting to collaborate with and inspire many brilliant minds.

Wei Wu, Associate Director:

Working at CONTINUUS has given me the opportunity to continue refining my technical knowledge, while growing in a friendly and motivating environment.


Sean Keenan, Process Engineer:

Every day brings a new adventure and challenge at CONTINUUS. It’s so exciting to walk around and see everyone working on so many interesting things!

Stephen Born, Director of Scientific Affairs:

At CONTINUUS, I get to design and implement continuous solutions to long-standing challenges to batch manufacturing processes.  Many of these continuous solutions are the result of a highly collaborative work environment that isn’t readily possible within traditional pharmaceutical organizations.  There are so many opportunities to improve the way we manufacture drugs and positively impact patient outcomes.

Job Offerings

Our employees are critical to our success. We empower them to build rewarding careers, driven by a culture of learning that inspires employees to reach higher and create impact. We look forward to meeting you.